OPRL1 Antikörper
-
- Target Alle OPRL1 Antikörper anzeigen
- OPRL1 (Opiate Receptor-Like 1 (OPRL1))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser OPRL1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- opiate receptor-like 1
- Isotyp
- IgG
- Top Product
- Discover our top product OPRL1 Primärantikörper
-
anti-Opiate Receptor-Like 1 (OPRL1) (AA 1-47) antibody
OPRL1 Reaktivität: Human, Maus, Ratte WB, ELISA, IF (cc), IF (p), ICC, IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 323-370) antibodyOPRL1 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (Middle Region) antibodyOPRL1 Reaktivität: Human, Maus, Ratte, Meerschweinchen, Rind (Kuh), Hund, Kaninchen, Ziege, Pferd, Schaf, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) antibodyOPRL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) antibodyOPRL1 Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 110-212) antibodyOPRL1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 1-370) antibodyOPRL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 110-212) antibodyOPRL1 Reaktivität: Human ELISA Wirt: Maus Monoclonal 2A11 unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (C-Term) antibodyOPRL1 Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) antibodyOPRL1 Reaktivität: Human, Maus, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB: 1:500-1:2000, IP: 1:200-1:1000, IHC: 1:20-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- OPRL1 (Opiate Receptor-Like 1 (OPRL1))
- Andere Bezeichnung
- OPRL1 (OPRL1 Produkte)
- Synonyme
- KOR-3 antikoerper, NOCIR antikoerper, OOR antikoerper, ORL1 antikoerper, KOR3 antikoerper, LC132 antikoerper, MOR-C antikoerper, OFQR antikoerper, Oprl antikoerper, XOR1 antikoerper, OPRL antikoerper, ORGC antikoerper, morc antikoerper, opioid related nociceptin receptor 1 antikoerper, opiate receptor-like 1 L homeolog antikoerper, opiate receptor-like 1 antikoerper, opioid receptor-like 1 antikoerper, OPRL1 antikoerper, oprl1.L antikoerper, LOC100335303 antikoerper, Oprl1 antikoerper
- Hintergrund
- Synonyms:OOR, ORL1 Background:G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins(G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.
- Molekulargewicht
- 45 kDa
- Gen-ID
- 4987
- UniProt
- P41146
-
